{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:44:42Z","timestamp":1697291082507},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T00:00:00Z","timestamp":1204070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s00774-007-0809-1","type":"journal-article","created":{"date-parts":[[2008,2,26]],"date-time":"2008-02-26T18:41:57Z","timestamp":1204051317000},"page":"185-190","source":"Crossref","is-referenced-by-count":1,"title":["Alterations in serum phosphate levels predict the long-term response to intravenous calcitriol therapy in dialysis patients with secondary hyperparathyroidism"],"prefix":"10.1007","volume":"26","author":[{"given":"Kiyoko","family":"Hosaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro James","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Iino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitake","family":"Gejyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,27]]},"reference":[{"key":"809_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1525-139X.2005.18408.x","volume":"18","author":"D.L. Andress","year":"2005","unstructured":"Andress DL (2005) Vitamin D treatment in chronic kidney disease. Semin Dial 18:315\u2013321","journal-title":"Semin Dial"},{"key":"809_CR2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1525-139X.2005.18404.x","volume":"18","author":"J.D. Hernandez","year":"2005","unstructured":"Hernandez JD, Wesseling K, Salusky IB (2005) Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial 18:290\u2013295","journal-title":"Semin Dial"},{"issue":"suppl5","key":"809_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/15.suppl_5.18","volume":"15","author":"M. Schoemig","year":"2000","unstructured":"Schoemig M, Ritz E (2000) Management of disturbed calcium metabolism in uraemic patients: use of vitamin D metabolites. Nephrol Dial Transplamt 15(suppl 5):18","journal-title":"Nephrol Dial Transplamt"},{"key":"809_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.mnh.0000172720.34229.39","volume":"14","author":"T.B. Drueke","year":"2005","unstructured":"Drueke TB (2005) Which vitamin D derivative to prescribe for renal patients. Curr Opin Nephrol Hypertens 14:343\u2013349","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"suppl5","key":"809_CR5","first-page":"39","volume":"15","author":"Clinical Algorithms on Renal Osteodystrophy","year":"2000","unstructured":"Clinical Algorithms on Renal Osteodystrophy (2000) Nephrol Dial Transp 15(suppl 5):39\u201357","journal-title":"Nephrol Dial Transp"},{"key":"809_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(03)00905-3","volume":"42","author":"G. Eknoyan","year":"2003","unstructured":"Eknoyan G, Levin A, Levin NW, National Kidney Foundation (2003) Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:1\u2013201","journal-title":"Am J Kidney Dis"},{"key":"809_CR7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0272-6386(97)90352-8","volume":"29","author":"C.H. Hsu","year":"1997","unstructured":"Hsu CH (1997) Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641\u2013649","journal-title":"Am J Kidney Dis"},{"key":"809_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000073945","volume":"23","author":"S.M. Moe","year":"2003","unstructured":"Moe SM, Drueke TB (2003) Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23:369\u2013379","journal-title":"Am J Nephrol"},{"key":"809_CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1525-139X.2005.18407.x","volume":"18","author":"G.O. Wolisi","year":"2005","unstructured":"Wolisi GO, Moe SM (2005) The role of vitamin D in vascular calcification in chronic kidney disease. Semin Dial 18:307\u2013314","journal-title":"Semin Dial"},{"issue":"suppl3","key":"809_CR10","first-page":"iii23","volume":"18","author":"M. Fukagawa","year":"2003","unstructured":"Fukagawa M, Nakanishi S (2003) Role of parathyroid intervention in the management of secondary hyperparathyroidism. Nephrol Dial Transplant 18(suppl 3):iii23\u2013iii26","journal-title":"Nephrol Dial Transplant"},{"key":"809_CR11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1744-9987.2006.00364.x","volume":"10","author":"Y. Tominaga","year":"2006","unstructured":"Tominaga Y, Inaguma D, Matsuoka S, Tahara H, Kukita K, Kurihara S, Onoda S, Tsuruta Y, Tsutsui S, Ohta K, Kuwahara M, Tanaka M, Nishizawa Y, PTG study group (2006) Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism? Ther Apher Dial 10:198\u2013204","journal-title":"Ther Apher Dial"},{"key":"809_CR12","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ndt\/gfg451","volume":"18","author":"S. Okuno","year":"2003","unstructured":"Okuno S, Ishimura E, Kitatani K, Chou H, Nagase K, Maekawa K, Izumotani T, Yamakawa T, Imanishi Y, Shoji T, Inaba M, Nishizawa Y (2003) Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism. Nephrol Dial Transplant 18:2613\u20132621","journal-title":"Nephrol Dial Transplant"},{"key":"809_CR13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000188261","volume":"68","author":"M. Fukagawa","year":"1994","unstructured":"Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E, Kurokawa K (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68:221\u2013228","journal-title":"Nephron"},{"key":"809_CR14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0272-6386(96)90252-8","volume":"28","author":"F. Malberti","year":"1996","unstructured":"Malberti F, Corradi B, Cosci P, Calliada F, Marecelli D, Imbasciati E (1996) Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism. Am J Kidney Dis 28:704\u2013712","journal-title":"Am J Kidney Dis"},{"issue":"suppl3","key":"809_CR15","first-page":"iii34","volume":"18","author":"N. Onoda","year":"2003","unstructured":"Onoda N, Kurihara S, Sakurai Y, Owada K, Osono E, Adachi H, Suga M, Yoneshima H (2003) Evaluation of blood supply to the parathyroid glands in secondary hyperparathyroidism compared with histopathology. Nephrol Dial Transplant 18(suppl 3): iii34\u2013iii37","journal-title":"Nephrol Dial Transplant"},{"key":"809_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1523-1755.1999.00538.x","volume":"56","author":"M. Rodriguez","year":"1999","unstructured":"Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Jimenez A, Torres A, Felsenfeld AJ (1999) Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int 56:306\u2013317","journal-title":"Kidney Int"},{"key":"809_CR17","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1681\/ASN.V251014","volume":"2","author":"M. Rodriguez","year":"1991","unstructured":"Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F (1991) The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2:1014\u20131020","journal-title":"J Am Soc Nephrol"},{"key":"809_CR18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10157-005-0342-2","volume":"9","author":"Y. Oyama","year":"2005","unstructured":"Oyama Y, Kazama JJ, Omori K, Higuchi N, Kameda S, Yamamoto S, Maruyama H, Narita I, Gejyo F (2005) Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism. Clin Exp Nephrol 9:142\u2013147","journal-title":"Clin Exp Nephrol"},{"key":"809_CR19","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","volume":"67","author":"J.J. Kazama","year":"2005","unstructured":"Kazama JJ, Sato F, Omori K, Hama H, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F (2005) Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients. Kidney Int 67:1120\u20131125","journal-title":"Kidney Int"},{"key":"809_CR20","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E. Slatopolsky","year":"1996","unstructured":"Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534\u20132540","journal-title":"J Clin Invest"},{"key":"809_CR21","first-page":"S2","volume":"73","author":"J. Silver","year":"1997","unstructured":"Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh-Many T (1997) Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int Suppl 73:S2\u2013S7","journal-title":"Kidney Int Suppl"},{"key":"809_CR22","first-page":"710","volume":"16","author":"J. Chudek","year":"2003","unstructured":"Chudek J, Piecha G, Kokot F, Wiecek A (2003) Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients. J Nephrol 16:710\u2013715","journal-title":"J Nephrol"},{"key":"809_CR23","first-page":"81","volume":"54","author":"A. Fournier","year":"2000","unstructured":"Fournier A (2000) Greater PTH suppression in dialysis patients taking sevelamer hydrochloride (Renagel). Clin Nephrol 54: 81\u201382","journal-title":"Clin Nephrol"},{"key":"809_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","volume":"55","author":"E.A. Slatopolsky","year":"1999","unstructured":"Slatopolsky EA, Burke SK, Dillon MA (1999) RenaGel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55: 299\u2013307","journal-title":"Kidney Int"},{"key":"809_CR25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","volume":"277","author":"T. Yamashita","year":"2000","unstructured":"Yamashita T, Yoshioka M, Itoh N (2000) Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277:494\u2013498","journal-title":"Biochem Biophys Res Commun"},{"key":"809_CR26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1744-9987.2005.00291.x","volume":"9","author":"J.J. Kazama","year":"2005","unstructured":"Kazama JJ, Gejyo F, Shigematsu T, Fukagawa M (2005) Role of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism. Ther Apher Dial 9:328\u2013330","journal-title":"Ther Apher Dial"},{"key":"809_CR27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","volume":"67","author":"S. Nakanishi","year":"2005","unstructured":"Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M (2005) Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 67: 1171\u20131178","journal-title":"Kidney Int"},{"key":"809_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semnephrol.2003.08.014","volume":"24","author":"N.X. Chen","year":"2004","unstructured":"Chen NX, Moe SM (2004) Vascular calcification in chronic kidney disease. Semin Nephrol 24:61\u201368","journal-title":"Semin Nephrol"},{"issue":"suppl4","key":"809_CR29","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1097\/01.ASN.0000081666.10967.05","volume":"9","author":"G.M. Chertow","year":"2003","unstructured":"Chertow GM (2003) Slowing the progression of vascular calcification in hemodialysis. J Am Soc Nephrol 9(suppl 4): S310\u2013S314","journal-title":"J Am Soc Nephrol"},{"key":"809_CR30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","volume":"19","author":"G.M. Chertow","year":"2004","unstructured":"Chertow GM, Raggi P, Chasan-Taber S, Bommer J, Holzer H, Burke SK (2004) Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1489\u20131496","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl2","key":"809_CR31","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1681\/ASN.2005060663","volume":"16","author":"J.A. Coladonato","year":"2005","unstructured":"Coladonato JA (2005) Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 16(suppl 2):S107\u2013S114","journal-title":"J Am Soc Nephrol"},{"key":"809_CR32","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"G.A. Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208\u20132218","journal-title":"J Am Soc Nephrol"},{"key":"809_CR33","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","volume":"12","author":"S.K. Ganesh","year":"2001","unstructured":"Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK (2001) Association of elevated serum PO(4), Ca \u00d7 PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131\u20132138","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-007-0809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-007-0809-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-007-0809-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T20:51:32Z","timestamp":1630788692000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-007-0809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s00774-007-0809-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}